BrundellI., D'AmicoY., SundströmB.TPA IRMA-M. A new assay for TPA based on monoclonal antibodies.J Tum Marker Oncol1993; 8: 71.
2.
MontinariF., LuporiniG.The tissue polypeptide antigen. In: BallestaA.M., TorreG.G., BombardieriE., GionM., MolinaR., eds. Updating on tumor markers in tissue and biological fluids.Torino: Minerva Medica1993; 639–50.
3.
GionM., MioneR., GattiC.Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA 15.3 and MCA.Tumori1990; 76: 360–4.
4.
GionM., MioneR., PappagalloG.L.Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator.Eur J Cancer1993; 29A/1: 66–9.
5.
GionM., MioneR., DittadiR.Carcinoembryonic antigen, ferritin and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.Cancer1986; 57: 917–22.
6.
GionM., MioneR., GattiC.Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.Breast Cancer Res Treat1990; 17: 15–21.
7.
CorrealeM., ParadisoA., AbbateI.Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activity.Tumor Biol1993; 14: 30–7.